Digital pathology company Proscia announced Tuesday it scooped up $37 million in Series C financing, per Mobi Health News.
The round includes participation from Highline Capital Management, Triangle Peak Partners and Alpha Intelligence Capital, as well as existing investors, including Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Managers and Razor’s Edge Ventures.
Proscia said the investment brings its total raise to $72 million, building on a $23 million Series B round from 2020. It plans to use the funds to build its commercial operations, including by hiring for sales, marketing and support teams, as well as adding distribution partnerships.
